Neuromuscular Electrical Stimulation in Patients With Prolonged Mechanical Ventilation (NMES)

July 26, 2021 updated by: Chen Yen-Huey, Chang Gung University

Effects of Neuromuscular Electrical Stimulation on Patients With Prolonged Mechanical Ventilation

Prolonged mechanical ventilation has been defined as the need for >21 days. The muscle weakness occurred most commonly in patients with PMV and resulted in increasing time to wean from mechanical ventilation, and longer stay in hospital.

Neuromuscular electrical stimulation (NMES) involves applying a stimuli to skeletal muscle, to trigger muscle contraction, and it can be used for the recovery of muscle mass and muscle strength following prolonged immobilization. NMES also improve microcirculation and systemic circulation in patients with cardiopulmonary diseases.

The purposes of this study:

  1. to examine the acute effects of NMES on the microcirculation, physiologic response and metabolic demand in patients with PMV.
  2. to investigate the training effects of NMES on microcirculation, muscle strength and weaning outcomes in patients with PMV.

METHODS: Subjects with PMV are recruited and are randomly assigned into NMES (n=20) or control group (n=20).The NMES group receive daily NMES for 30 min/session for 10 days. The assessment of muscle strength and weaning profile were performed before and after intervention. During the first and the last NMES session, the status of microcirculation and local muscle tissue oxygenation will be measured by NIRS, and the metabolic status will be measured by IC. The ventilator weaning rate and length of stay in RCC will be recorded.

Study Overview

Status

Completed

Detailed Description

Scientific and technologic advances in medicine have resulted in the ability of the medical team to prolong life. One consequence of life-extending advancements in technology is the increasing numbers of patients requiring prolonged mechanical ventilation (PMV). Prolonged mechanical ventilation has been defined as the need for 21 days, of consecutive mechanical ventilation for six hours/day. The interaction of underlying diseases and prolong bedridden result in various complication in patients with PMV. Known complications can include: muscle weakness, atelectasis, and deconditioning. The muscle weakness occurred most commonly in patients with PMV and resulted in increasing time to wean successfully from mechanical ventilation, and longer stay in hospital. Exercise is effective in improving muscle strength and physical function in patients with heart failure and chronic obstructive pulmonary disease (COPD. However, patients with PMV may be too fragile to perform excise. Neuromuscular electrical stimulation (NMES) involves applying a series of stimuli to skeletal muscle, primarily to trigger muscle contraction, and it can be used for the recovery of muscle mass and muscle strength following prolonged immobilization. NMES also improve microcirculation and systemic circulation in patients with cardiopulmonary diseases. In addition, the application of NMES increases oxygen consumption of whole body and elicits physiologic effects that are similar to aerobic exercise. However, the effects of NMES on the PMV population remain unclear. Near-infrared spectroscopy (NIRS) is a recently developed noninvasive method of measuring tissue oxygenation, blood flow, and local tissue metabolism. NIRS combined with a vascular occlusion test is proposed as a tool to assess the microvascular response. Indirect calorimetry (IC) uses the method of breath-bybreath monitoring by pneumotachography to measure oxygen consumption (VO2) and carbon dioxide production (VCO2).

The purposes of this study:

  1. to examine the acute effects of NMES on the microcirculation, physiologic response and metabolic demand in patients with PMV.
  2. to investigate the training effects of NMES on microcirculation, muscle strength and weaning outcomes in patients with PMV. METHODS: Subjects who have been on ventilator for>= 21 days are recruited form respiratory care center (RCC) and are randomly assigned into NMES (n=20) or control group (n=20).The NMES group receive daily NMES for 30 min/session for 10 days. The assessment of muscle strength and weaning profile were performed before and after intervention. During the first and the last NMES session, the status of microcirculation and local muscle tissue oxygenation will be measured by NIRS, and the metabolic status will be measured by IC. The mechanical ventilator weaning outcomes and length of stay in RCC will be recorded. The results of this study help us to confirm whether the application of NMES is beneficial in the improvement of muscle strength in patients with PMV, and to furtherly understand the mechanisms. The results may provide an alternative options for clinicians functional and hospitalization outcomes in patients with PMV.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • TaoYuan City, Taiwan, 333
        • Chang Gung University
      • Taoyuan, Taiwan, 333
        • Dept of Respiratory therapy, Chang Gung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age ≧ 20 years;
  2. MV for > 6 h/day for > 21 days; and
  3. medical stability, absence of signs and symptoms of infection, and hemodynamic stability).
  4. hemodynamic stable without or with a low dose of vasopressor ((Dopamine or Dobutamine <5μg/kg/min)

Exclusion Criteria:

  1. acute lung or systemic infection,
  2. ongoing neuromuscular disease (e.g., myasthenia gravis, Guillain-Barre disease)
  3. bone contracture or skin lesion
  4. obesity [body mass index (BMI) >35 kg/m2].
  5. disease at end-stage with expecting survival <=6month
  6. pregnancy
  7. severe edema (deep indentation when pressing a finger into the skin, requiring >30 s to rebound

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: electrical stimulation
receive daily NMES for 30 min/session for 10 days.
Participants will receive muscular electrical stimulation on quadriceps muscle and abdominal muscles for 30 min/day for 10 days
SHAM_COMPARATOR: Control
receive similar electrical stimulation (ES) procedure as those in the intervention group but with ES machine power off.
Participants will receive muscular electrical stimulation on quadriceps muscle and abdominal muscles for 30 min/day for 10 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tissue oxygenation
Time Frame: the 1st day of intervention
local muscle tissue oxygenation
the 1st day of intervention
tissue oxygenation
Time Frame: the 10th day of intervention
local muscle tissue oxygenation
the 10th day of intervention
muscle strength
Time Frame: the 1st day of intervention
Medical research council score. The score ranges from a 0 points (zero strength) to 5 points (good)
the 1st day of intervention
muscle strength
Time Frame: the 10th day of intervention
Medical research council score. The score ranges from a 0 points (zero strength) to 5 points (good).
the 10th day of intervention
pulmonary function (maximal inspiratory pressure)
Time Frame: the 1st day of intervention
pressure gauge
the 1st day of intervention
pulmonary function (maximal inspiratory pressure)
Time Frame: the 10th day of intervention
pressure gauge
the 10th day of intervention
oxygen consumption
Time Frame: the 1st day of intervention
the amount of oxygen that body consume, is measured by indirect calorimetry
the 1st day of intervention
oxygen consumption
Time Frame: the 10th day of intervention
the amount of oxygen that body consume, is measured by indirect calorimetry
the 10th day of intervention
energy expenditure (calories)
Time Frame: the 1st day of intervention
the amount of energy expenditure which is measured by indirect calorimetry
the 1st day of intervention
energy expenditure (calories)
Time Frame: the 10th day of intervention
the amount of energy expenditure which is measured by indirect calorimetry
the 10th day of intervention
pulmonary function (rapid shallow breathing index)
Time Frame: the 1st day of intervention
respiratory rate/tidal volume
the 1st day of intervention
pulmonary function (rapid shallow breathing index)
Time Frame: the 10th day of intervention
respiratory rate/tidal volume
the 10th day of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weaning rate
Time Frame: through study completion, an maximal 42 days
ventilator weaning results (weaning successful/failure)
through study completion, an maximal 42 days
length of stay in respiratory care center
Time Frame: through study completion, an maximal 42 days
the total days of stay in respiratory care center
through study completion, an maximal 42 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 25, 2019

Primary Completion (ACTUAL)

January 31, 2021

Study Completion (ACTUAL)

January 31, 2021

Study Registration Dates

First Submitted

August 29, 2019

First Submitted That Met QC Criteria

August 30, 2019

First Posted (ACTUAL)

September 3, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 28, 2021

Last Update Submitted That Met QC Criteria

July 26, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolonged Mechanical Ventilation

Clinical Trials on neuromuscular electrical stimulation

3
Subscribe